The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

Mon, 12th Mar 2018 10:43

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at 1,598.50 pence. Credit Suisse raised its price target on the budget airline to 1,836p from 1,803p, and reiterated its Outperform rating. ----------FTSE 100 - LOSERS----------Just Eat, down 4.0%. Deutsche Bank downgraded the online takeaway platform to Sell from Hold.Randgold Resources, down 1.6%, Fresnillo, down 1.7%. The gold miners were tracking spot gold prices lower quoted at USD1,316.93 an ounce compared to USD1,322.64 at the London equities close Friday.----------FTSE 250 - WINNERS----------Cairn Energy, up 3.5%. Morgan Stanley raised the oil and gas explorer to Overweight from Equal Weight.----------FTSE 250 - LOSERS----------Vectura, down 5.3%, Hikma Pharmaceuticals, down 3.3%. Vectura and Hikma said they do not expect approval and launch for their US generic version of GlaxoSmithKline's Advair Diskus chronic obstructive pulmonary disease treatment until 2020 after US regulators upheld their objections. In May 2017, the US Food & Drug Administration issued a complete response letter with regard to its abbreviated new drug application for its generic version VR315. Subsequently, Hikma and Vectura managed to resolve all but one issue raised by the FDA. In November 2017, Hikma and Vectura began a dispute resolution process regarding the remaining outstanding issue with the FDA. The issue was related to the FDA requesting the firms complete an additional clinical endpoint study. On Monday, the two firms announced the FDA upheld its original decision.Melrose Industries, down 3.5%. The industrial turnaround specialist raised its offer to buy engineer GKN to GBP8.10 billion in cash and shares from the initial GBP7.4 million bid in January, saying its new offer is final. Melrose increased its bid to 1.69 Melrose shares for every GKN share held, plus an unchanged 81p in cash, together equivalent to 467p per share based on Melrose's share price at close on Friday. Shareholders also would be entitled to receive the 6.2p final GKN dividend. Melrose noted its new offer represents a 43% premium to the 326.3 pence closing price of GKN on January 5, the day before its initial approach to GKN was announced. GKN advised shareholders to wait after it said it was "evaluating" the improved offer. GKN shares were up 0.7% at 438.13p. Polymetal International, down 2.9%. The gold miner said higher costs and the absence of foreign exchange gains led to a fall in 2017 earnings, as the company reiterated its annual gold and production guidance for the next two years. The company recorded a profit of USD354 million for 2017, down 10% from USD395 million in the year ago period, on a revenue of USD1.82 billion and USD1.58 billion, respectively. The 15% year-on-year rise in revenue was primarily driven by growth in gold production and sales. However, net profit attributable to shareholders fell to USD444 million in 2017 from USD619 million. Adjusted earnings before interest, taxes, depreciation and amortisation fell 2% year-on-year to USD745 million due to increased costs. The adjusted Ebitda margin fell to 41% from 48%. Virgin Money, down 2.9%. Jefferies cut the challenger bank to Hold from Buy.----------
More News
1 Oct 2021 10:22

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

Read more
29 Sep 2021 09:23

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

(Adds background)LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British supermarket Morrisons will be decided at an auction on Saturday, when two U.S. private equity groups will go head-to-head in up to five rounds of bids.Britain's Takeover...

Read more
20 Sep 2021 13:35

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

Read more
16 Sep 2021 11:29

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

Read more
16 Sep 2021 09:07

TOP NEWS: Vectura shareholders accept Philip Morris takeover

TOP NEWS: Vectura shareholders accept Philip Morris takeover

Read more
16 Sep 2021 08:02

Philip Morris seals contentious Vectura takeover

(Sharecast News) - Philip Morris International has taken control of Vectura after the cigarette company's contentious bid was supported by owners of almost 75% of the inhaler maker's shares.

Read more
16 Sep 2021 07:33

UPDATE 3-Philip Morris seals deal for UK's Vectura despite health group concerns

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds comment from health group; background on deal)By Pushkala Aripaka and Siddh...

Read more
16 Sep 2021 07:33

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds detail, background)By Pushkala AripakaSept 16 (Reuters) - Cigarette maker P...

Read more
14 Sep 2021 18:24

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

Read more
8 Sep 2021 07:49

UPDATE 3-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds detail, shares)By James DaveyLONDON, Sept 8 (...

Read more
8 Sep 2021 07:49

UPDATE 2-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds details, shares)By James DaveyLONDON, Sept 8 ...

Read more
8 Sep 2021 07:28

UPDATE 2-UK's Smiths to sell medical division to ICU for $2.4 bln, snubs TA

* Smiths Group agrees sale of unit to ICU Medical* Withdraws recommendation for TA Associates deal* Shares up 4%, biggest riser on the FTSE 100 index (Adds shares, ICU Medical statement, background)By Yadarisa ShabongSept 8 (Reuters) - British indus...

Read more
19 Aug 2021 14:32

Philip Morris snaps up more Vectura shares ahead of deal deadline

(Sharecast News) - US tobacco giant Philip Morris has bought up more shares of London-listed inhaler maker Vectura.

Read more
19 Aug 2021 10:47

Philip Morris lifts Vectura stake to 29%, halts further market trades

Philip Morris lifts Vectura stake to 29%, halts further market trades

Read more
18 Aug 2021 10:27

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.